Abstract
Background: Up-regulated pyruvate dehydrogenase kinase isoforms (PDKs) are associated with impaired glucose homeostasis in diabetes. Results: Novel PDK inhibitors were developed using structure-based design, which improves glucose tolerance with reduced hepatic steatosis in diet-induced obese mice. Conclusion: Obesity phenotypes are effectively treated by chemical intervention with PDK inhibitors. Significance: PDKs are potential drug targets for obesity and type 2 diabetes.
Original language | English (US) |
---|---|
Pages (from-to) | 4432-4443 |
Number of pages | 12 |
Journal | Journal of Biological Chemistry |
Volume | 289 |
Issue number | 7 |
DOIs | |
State | Published - Feb 14 2014 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology